CAPTRUST Financial Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,338
Closed -$209K 2767
2023
Q3
$209K Sell
4,338
-144
-3% -$8.55K ﹤0.01% 2256
2023
Q2
$306K Sell
4,482
-68
-1% -$4.39K ﹤0.01% 1954
2023
Q1
$221K Buy
4,550
+574
+14% +$30.3K ﹤0.01% 1988
2022
Q4
$240K Buy
+3,976
New +$233K ﹤0.01% 1830
2022
Q3
Sell
-1,177
Closed -$32K 3533
2022
Q2
$32K Sell
1,177
-143
-11% -$4.18K ﹤0.01% 3086
2022
Q1
$48K Sell
1,320
-111
-8% -$4K ﹤0.01% 2807
2021
Q4
$71K Sell
1,431
-572
-29% -$31.7K ﹤0.01% 2408
2021
Q3
$143K Buy
2,003
+1,346
+205% +$83.6K ﹤0.01% 1794
2021
Q2
$34K Sell
657
-27
-4% -$842 ﹤0.01% 2757
2021
Q1
$17K Buy
684
+665
+3,500% +$12.5K ﹤0.01% 3116
2020
Q4
$0 Buy
+19
New +$225 ﹤0.01% 3486

Other funds holding PRTA

CAPTRUST Financial Advisors's PRTA Position: Q4 2023 in Review

CAPTRUST Financial Advisors sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 4,338 shares — an estimated $209K sold.

CAPTRUST Financial Advisors first reported a position in PRTA in Q4 2020 and held it in 11 quarters. The position peaked at $306K in Q2 2023. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • CAPTRUST Financial Advisors reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 4,338 Prothena Corp shares in Q4 2023, an estimated $209K.
  • CAPTRUST Financial Advisors first reported a position in Prothena Corp in Q4 2020 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Prothena Corp position peaked at $306K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.